Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-660
Closed -$47.2K 275
2023
Q4
$47.2K Buy
660
+38
+6% +$2.65K 0.1% 176
2023
Q3
$43.2K Buy
622
+71
+13% +$5.37K 0.02% 222
2023
Q2
$44.6K Buy
+551
New +$45K 0.03% 229

Other funds holding HOLX

West Tower Group's HOLX Position: Q1 2024 in Review

West Tower Group sold out of Hologic (HOLX) in Q1 2024, closing a stake of 660 shares — an estimated $47.2K sold.

West Tower Group first reported a position in HOLX in Q2 2023 and held it in 3 quarters. The position peaked at $47.2K in Q4 2023. 705 funds tracked by Wall St. Rank hold HOLX as of Q1 2024.

  • West Tower Group reported no remaining Hologic position as of Q1 2024 after selling out during the quarter.
  • West Tower Group sold 660 Hologic shares in Q1 2024, an estimated $47.2K.
  • West Tower Group first reported a position in Hologic in Q2 2023 and held it in 3 quarters.
  • West Tower Group's Hologic position peaked at $47.2K in Q4 2023.
  • 705 funds tracked by Wall St. Rank held Hologic as of Q1 2024.

Based on West Tower Group's 13F filing for Q1 2024, filed 14 May 2024.